Literature DB >> 30315105

Transcriptional repressor GATA binding 1-mediated repression of SRY-box 2 expression suppresses cancer stem cell functions and tumor initiation.

Xue Gong1,2, Weiguang Liu2, Lele Wu2, Zhifang Ma2, Yuzhi Wang1,2, Shiyi Yu2, Jun Zhang2, Hao Xie1, Guanyun Wei2, Fei Ma2, Ling Lu3,4, Liming Chen5,2.   

Abstract

Cancer stem cells (CSCs) have been reported in a variety of cancers. SRY-box 2 (SOX2) is a member of the SOX family of transcription factors and has been shown to play a critical role in maintaining the functions of CSCs and promoting tumor initiation. However, the underlying mechanisms for the transcriptional regulation of the SOX2 gene in CSCs are unclear. In this study, using in silico and experimental approaches, we identified transcriptional repressor GATA binding 1 (TRPS1), an atypical GATA-type transcription factor, as a critical transcriptional regulator that represses SOX2 expression and thereby suppresses cancer stemness and tumorigenesis. Mechanistically, TRPS1 repressed SOX2 expression by directly targeting the consensus GATA-binding element in the SOX2 promoter as elucidated by ChIP and luciferase reporter assays. Of note, in vitro mammosphere formation assays in culture and in vivo xenograft tumor initiation experiments in mouse models revealed that TRPS1-mediated repression of SOX2 expression suppresses CSC functions and tumor initiation. Taken together, our study provides detailed mechanistic insights into CSC functions and tumor initiation by the TRPS1-SOX2 axis.
© 2018 Gong et al.

Entities:  

Keywords:  GATA-binding element; SOX2; TRPS1; breast cancer; cancer biology; cancer stem cells; cancer stemness; carcinogenesis; gene expression; transcription regulation; tumor initiation

Mesh:

Substances:

Year:  2018        PMID: 30315105      PMCID: PMC6290167          DOI: 10.1074/jbc.RA118.003983

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  40 in total

1.  GATA factors efficiently direct cardiac fate from embryonic stem cells.

Authors:  Harma K Turbendian; Miriam Gordillo; Su-Yi Tsai; Jia Lu; Guoxin Kang; Ting-Chun Liu; Alice Tang; Susanna Liu; Glenn I Fishman; Todd Evans
Journal:  Development       Date:  2013-03-13       Impact factor: 6.868

Review 2.  The multiple roles for Sox2 in stem cell maintenance and tumorigenesis.

Authors:  Kuancan Liu; Baoshun Lin; Meng Zhao; Xiangyue Yang; Min Chen; Anding Gao; Fei Liu; Jianwen Que; Xiaopeng Lan
Journal:  Cell Signal       Date:  2013-02-15       Impact factor: 4.315

Review 3.  The cancer stem cell: premises, promises and challenges.

Authors:  Hans Clevers
Journal:  Nat Med       Date:  2011-03       Impact factor: 53.440

4.  GATA Transcription Factors and Cancer.

Authors:  Rena Zheng; Gerd A Blobel
Journal:  Genes Cancer       Date:  2010-12

Review 5.  Targeting cancer stem cells to suppress acquired chemotherapy resistance.

Authors:  S J Vidal; V Rodriguez-Bravo; M Galsky; C Cordon-Cardo; J Domingo-Domenech
Journal:  Oncogene       Date:  2013-10-07       Impact factor: 9.867

6.  Trps1 plays a pivotal role downstream of Gdf5 signaling in promoting chondrogenesis and apoptosis of ATDC5 cells.

Authors:  Shunji Itoh; Seiji Kanno; Zhibo Gai; Hiroki Suemoto; Motohisa Kawakatsu; Hiroyuki Tanishima; Yoshifumi Morimoto; Katsuhiro Nishioka; Ikuji Hatamura; Munehito Yoshida; Yasuteru Muragaki
Journal:  Genes Cells       Date:  2008-04       Impact factor: 1.891

7.  Mutation of GATA3 in human breast tumors.

Authors:  Jerry Usary; Victor Llaca; Gamze Karaca; Shafaq Presswala; Mehmet Karaca; Xiaping He; Anita Langerød; Rolf Kåresen; Daniel S Oh; Lynn G Dressler; Per E Lønning; Robert L Strausberg; Stephen Chanock; Anne-Lise Børresen-Dale; Charles M Perou
Journal:  Oncogene       Date:  2004-10-07       Impact factor: 9.867

8.  Sox2: a possible driver of the basal-like phenotype in sporadic breast cancer.

Authors:  Socorro M Rodriguez-Pinilla; David Sarrio; Gema Moreno-Bueno; Yolanda Rodriguez-Gil; Miguel A Martinez; Lucia Hernandez; David Hardisson; Jorge S Reis-Filho; Jose Palacios
Journal:  Mod Pathol       Date:  2007-03-02       Impact factor: 7.842

9.  NCBI GEO: archive for functional genomics data sets--10 years on.

Authors:  Tanya Barrett; Dennis B Troup; Stephen E Wilhite; Pierre Ledoux; Carlos Evangelista; Irene F Kim; Maxim Tomashevsky; Kimberly A Marshall; Katherine H Phillippy; Patti M Sherman; Rolf N Muertter; Michelle Holko; Oluwabukunmi Ayanbule; Andrey Yefanov; Alexandra Soboleva
Journal:  Nucleic Acids Res       Date:  2010-11-21       Impact factor: 16.971

10.  Sox2 promotes tamoxifen resistance in breast cancer cells.

Authors:  Marco Piva; Giacomo Domenici; Oihana Iriondo; Miriam Rábano; Bruno M Simões; Valentine Comaills; Inmaculada Barredo; Jose A López-Ruiz; Ignacio Zabalza; Robert Kypta; Maria d M Vivanco
Journal:  EMBO Mol Med       Date:  2014-01       Impact factor: 12.137

View more
  4 in total

Review 1.  Emerging Role of SOX Proteins in Breast Cancer Development and Maintenance.

Authors:  Gaurav A Mehta; Pooja Khanna; Michael L Gatza
Journal:  J Mammary Gland Biol Neoplasia       Date:  2019-05-09       Impact factor: 2.673

2.  Bioinformatics analyses and biological function of lncRNA ZFPM2-AS1 and ZFPM2 gene in hepatocellular carcinoma.

Authors:  Yi Luo; Xiaojun Wang; Ling Ma; Zhihua Ma; Shen Li; Xiaoyu Fang; Xiangyu Ma
Journal:  Oncol Lett       Date:  2020-03-27       Impact factor: 2.967

3.  Single-Cell RNA-Seq Reveals the Promoting Role of Ferroptosis Tendency During Lung Adenocarcinoma EMT Progression.

Authors:  Jiaxi Yao; Yuchong Zhang; Mengling Li; Zuyu Sun; Tao Liu; Mingfang Zhao; Zhi Li
Journal:  Front Cell Dev Biol       Date:  2022-01-20

Review 4.  Advances in Biomarkers and Endogenous Regulation of Breast Cancer Stem Cells.

Authors:  Wenmin Chen; Lu Zhang; Suling Liu; Ceshi Chen
Journal:  Cells       Date:  2022-09-20       Impact factor: 7.666

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.